Navigation Links
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
Date:4/6/2012

protocol will evaluate the Magellan MAR01™ technology's role in treating wounded warriors at risk for long-term complications due to Compartment Syndrome, an acute condition that results from a rapid build up of fluid pressure in soft tissue compartments following trauma or severe inflammatory events. The elevated pressure collapses the blood vessels that perfuse muscle and bone, which can result in permanent tissue death, disability and amputation of the affected limb.

"We've been thrilled to partner with Arteriocyte in development of point-of-care cellular therapies," said Joseph Wenke, PhD, Manager of ISR's Extremity Trauma and Regenerative Medicine Task Area and the Orthopaedic Extremity Trauma Research Program. "This program is another example of the Institute for Surgical Research's efforts to improve stabilization, retention and readiness for thousands of our Wounded Warriors. We're pleased that Arteriocyte is ready to take this treatment into the clinic."

Retired Army Col., Dr. John Kragh, Orthopaedic Surgeon and researcher at the ISR, and Arteriocyte's Program Officer added, "Compartment Syndrome and the associated complications are a major challenge in Combat Casualty Care, resulting in elevated rates of amputations. This treatment represents an important potential tool to improve success of limb salvage for these patients."

Enrollment into the Compartment Syndrome clinical trial is anticipated to commence immediately following final approval by the Army's Human Research Protections Office. The study will be performed at The Ohio State University Wexner Medical Center, led by Dr. Jason Calhoun, Chair, Department of Orthopaedics, and Frank J. Kloenne, Chair in Orthopaedic Surgery.

Arteriocyte CEO Don Brown said, "We consider it our responsibility to help focus on improving care delivery for our men and women in uniform. During the past five years, we have worked hard to make Arteriocyte's technologies available to those me
'/>"/>

SOURCE Arteriocyte
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
2. Arteriocyte Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use
3. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
4. Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial
5. Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010
6. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
7. Rensselaer professor Jie Lian receives NSF CAREER Award
8. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
9. Watsons Generic BONIVA® 150mg Receives FDA Approval
10. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Decision Resources Group finds that the ... Russia , India and ... in 2013, roughly equal to the size of the ... BRIC market will experience much faster growth as a result of ... Other key findings from Decision Resources Group,s coverage of ...
(Date:8/20/2014)... nerves in your ear could improve the health of ... the University of Leeds used a standard TENS machine ... electrical pulses to the tragus, the small raised flap ... of the ear canal. , The stimulation changed the ... reducing the nervous signals that can drive failing hearts ...
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets  has announced ... Global Strategic Business Report" report to their offering. ... Culture Supplies in US$ Thousands by the following Product Segments: Media, ... for the US, Canada , Japan ... , and Latin America . Annual estimates and ...
(Date:8/19/2014)... XenoTech announces an exclusive partnership with ... from bioactive small molecules. Based on an ... convenient and timely assessment of critical metabolite and ... of Commercial Operations, Christian Darabant, “the value of ... be measured directly by comparison with the approximate ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3'Tickling' your ear could be good for your heart 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3
... Calif., Nov. 3 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... results for the third quarter ended September 30, 2009, and ... we reached the 320th event target in our pivotal Phase ... of small cell lung cancer. This event allowed us ...
... ... consulting firm Full Spectrum Software announces key hire. Cindy Larkin has been hired ... software experience to her new role. , ... Southborough, MA (Vocus) November 3, 2009 -- Leading medical device ...
... , - Follow-On Results from ... Demonstrate Efficacy of Nimotuzumab Without Severe, Class-Associated, ... YM BioSciences Inc. (NYSE Amex: YMI ; TSX: YM), ... a diverse portfolio of promising cancer-related products at various stages ...
Cached Biology Technology:Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 7Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 2YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009 2YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009 3YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009 4YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009 5
(Date:8/20/2014)... DENVER (August 20, 2014) Women who are poor ... to infants with elevated levels of the stress hormone, ... later in life, according to a new research from ... online recently in the American Journal of Human ... infants and relate it directly to the socioeconomic status ...
(Date:8/20/2014)... YORK and POINT ROBERTS, Washington ... Biometrics Play a Key Role in Addressing Security Concerns in ... ), a global news source covering leading sectors including biometrics, ... wallet market. Jason Peaslee , Managing Partner ... Institute and Gino Pereira , CEO of NXT-ID, Inc. ...
(Date:8/19/2014)... German . ... a large amount of electricity is to be produced with ... to be stored during productive periods so that these fluctuations ... from adequate for the purpose. Science and industry are therefore ... battery systems that used to be too expensive or unsophisticated ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... The brain may interpret the information it receives from ... previously thought, according to new research from the National ... By studying how monkeys perceive a vibrating object when ... an animal's attention over time influence how a sensory ...
... by researchers at the University of Illinois at Urbana-Champaign indicates ... deep ocean will change with climate change. , The direct ... suggested as one method to help control rising carbon dioxide ... warming. But, because the atmosphere interacts with the oceans, the ...
... have for the first time used gene therapy to ... in an animal model that is genetically susceptible to ... edition of the journal Circulation, the authors say that ... therapeutic gene throughout the body. , "Previous attempts at ...
Cached Biology News:Cracking the perception code 2Cracking the perception code 3How 'Dirt' Could Educate The Immune System And Help Treat Asthma 2Gene therapy reverses genetic mutation responsible for heart failure in muscular dystrophy 2Gene therapy reverses genetic mutation responsible for heart failure in muscular dystrophy 3Gene therapy reverses genetic mutation responsible for heart failure in muscular dystrophy 4
Agarose, Biotechnology grade, 500g...
... UltraMount Plus is formulated for covering tissue sections ... alcohol soluble OR alcohol insoluble end products. ... such as Fast Red or AEC that require ... not, such as DAB. No heating is required ...
... (IC) Fixation Buffer, used in conjunction ... 00-8333), can be used to fix ... intracellular staining of cytokines and other ... have been specially formulated for reducing ...
Cytofix Buffer 100 mls...
Biology Products: